Abstract
Vaccine makers varied widely in their engagement with global public health efforts to broaden access to COVID-19 immunizations. Ethically motivated leadership was a dominant factor.
Original language | English |
---|---|
Journal | MIT Sloan Management Review |
Publication status | Accepted/In press - 31 Jul 2024 |